Literature DB >> 19950006

Pharmacogenetics of membrane transporters: an update on current approaches.

Tristan M Sissung1, Caitlin E Baum, C Tyler Kirkland, Rui Gao, Erin R Gardner, William D Figg.   

Abstract

This review provides an overview of the pharmacogenetics of membrane transporters including selected ABC transporters (ABCB1, ABCC1, ABCC2, and ABCG2) and OATPs (OATP1B1 and OATP1B3). Membrane transporters are heavily involved in drug clearance and alters drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have significant effects on the absorption, distribution, metabolism and excretion of compounds, and may alter pharmacodynamics of many agents. This review discusses the techniques used to identify substrates and inhibitors of these proteins and subsequently to assess the effect of genetic mutation on transport, both in vitro and in vivo. A comprehensive list of substrates for the major drug transporters is included. Finally, studies linking transporter genotype with clinical outcomes are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19950006      PMCID: PMC6362991          DOI: 10.1007/s12033-009-9220-6

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  105 in total

1.  Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8).

Authors:  Katrin Letschert; Dietrich Keppler; Jörg König
Journal:  Pharmacogenetics       Date:  2004-07

2.  Single nucleotide polymorphisms modify the transporter activity of ABCG2.

Authors:  Kuniaki Morisaki; Robert W Robey; Csilla Ozvegy-Laczka; Yasumasa Honjo; Orsolya Polgar; Kenneth Steadman; Balázs Sarkadi; Susan E Bates
Journal:  Cancer Chemother Pharmacol       Date:  2005-04-19       Impact factor: 3.333

3.  ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

Authors:  J E Keskitalo; O Zolk; M F Fromm; K J Kurkinen; P J Neuvonen; M Niemi
Journal:  Clin Pharmacol Ther       Date:  2009-05-27       Impact factor: 6.875

4.  Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17.

Authors:  Mikko Niemi; Pertti J Neuvonen; Ute Hofmann; Janne T Backman; Matthias Schwab; Dieter Lütjohann; Klaus von Bergmann; Michel Eichelbaum; Kari T Kivistö
Journal:  Pharmacogenet Genomics       Date:  2005-05       Impact factor: 2.089

5.  Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia.

Authors:  Tristan M Sissung; Klaus Mross; Seth M Steinberg; Dirk Behringer; William D Figg; Alex Sparreboom; Stephan Mielke
Journal:  Eur J Cancer       Date:  2006-09-06       Impact factor: 9.162

6.  Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.

Authors:  Ai Tamura; Kanako Wakabayashi; Yuko Onishi; Misako Takeda; Yoji Ikegami; Seigo Sawada; Masahisa Tsuji; Yoichi Matsuda; Toshihisa Ishikawa
Journal:  Cancer Sci       Date:  2007-02       Impact factor: 6.716

7.  Functional analysis of SNPs variants of BCRP/ABCG2.

Authors:  Chihiro Kondo; Hiroshi Suzuki; Masaya Itoda; Shogo Ozawa; Jun-ichi Sawada; Daisuke Kobayashi; Ichiro Ieiri; Kazunori Mine; Kenji Ohtsubo; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

Review 8.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

Review 9.  Clinical aspects of the MDR1 (ABCB1) gene polymorphism.

Authors:  Michel Eichelbaum; Martin F Fromm; Matthias Schwab
Journal:  Ther Drug Monit       Date:  2004-04       Impact factor: 3.681

10.  Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.

Authors:  P Wils; V Phung-Ba; A Warnery; D Lechardeur; S Raeissi; I J Hidalgo; D Scherman
Journal:  Biochem Pharmacol       Date:  1994-10-07       Impact factor: 5.858

View more
  36 in total

Review 1.  Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.

Authors:  Tristan M Sissung; Sarah M Troutman; Tessa J Campbell; Heather M Pressler; Hyeyoung Sung; Susan E Bates; William D Figg
Journal:  Discov Med       Date:  2012-01       Impact factor: 2.970

2.  Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males.

Authors:  Gary A Herman; Goutam C Mistry; Bingming Yi; Arthur J Bergman; Amy Q Wang; Wei Zeng; Li Chen; Karen Snyder; Jon L Ruckle; Patrick J Larson; Michael J Davies; Ronald B Langdon; Keith M Gottesdiener; John A Wagner
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

3.  Genes potentially associated with resistance of lung cancer cells to paclitaxel.

Authors:  K N Kashkin; E A Musatkina; A V Komelkov; D A Sakharov; E V Trushkin; E A Tonevitsky; T V Vinogradova; E P Kopantzev; M V Zinovyeva; O V Kovaleva; K A Arkhipova; I B Zborovskaya; A G Tonevitsky; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2011-05-18       Impact factor: 0.788

Review 4.  Targeting intratumoral androgens: statins and beyond.

Authors:  Michael T Schweizer; Evan Y Yu
Journal:  Ther Adv Med Oncol       Date:  2016-05-11       Impact factor: 8.168

Review 5.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

6.  Evaluation of pharmacokinetic and pharmacodynamic parameters following single dose of sitagliptin in healthy Indian males.

Authors:  Ganesh V Sangle; Mohan Patil; Nitin J Deshmukh; Sushant A Shengule; Shantibhushan Kamble; Kiran Kumar Vuppalavanchu; Sushil Kale; Mirza Layeeq Ahmed Baig; Geetchandra Singh; Javed Shaikh; Jitendra Tripathi; P Aravindababu
Journal:  Eur J Clin Pharmacol       Date:  2018-03-06       Impact factor: 2.953

Review 7.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

Review 8.  New insights in bilirubin metabolism and their clinical implications.

Authors:  Eva Sticova; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

9.  High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?

Authors:  Hala O El Mesallamy; Wafaa M Rashed; Nadia M Hamdy; Nayera Hamdy
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-10       Impact factor: 4.553

10.  Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.

Authors:  Hana Salimizand; Sabrieh Amini; Mohammad Abdi; Bayazid Ghaderi; Namam-Ali Azadi
Journal:  Tumour Biol       Date:  2015-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.